Table 3.
Selected differentially expressed miRNAs in CCPRCC, CCRCC, and PRCC
| miRNA | CCPRCC | CCRCC | PRCC | Selected validated targets a |
|---|---|---|---|---|
| miR-210 | Up | Up | NS | EFNA, MNT, VMP1 |
| miR-155 | Up | Up | NS | AGTR1, BACH1, LDOC1 |
| miR106b | Up | Up | NS | E2F1, VEGFA, CDKN1A |
| miR-15a | Up | Up | NS | BCL2, VEGFA, PDCD4 |
| miR-18a | Up | Up | NS | BIM, CTGF, ESR1 |
| miR-130a | Up | NS | NS | – |
| miR135b | Up | NS | NS | APC |
| miR-101 | Up | NS | NS | – |
| miR-10b | NS | Down | Down | HOXD10, KLF4, SFRS1 |
| miR-141 | NS | Down | - | CLOCK, SERBP1, ELMO2 |
| miR-200a | NS | Down | Down | ZEB1, ZEB2, ELMO2 |
| miR-200b | NS | Down | Down | ZEB1, ZEB2, ELMO2 |
| miR-200c | NS | Down | Down | ZEB1, ERRFI1, JAG1 |
| miR-26a | NS | Down | Down | SMAD1, PLAG1, TGFBR2 |
| miR-218 | NS | Down | Down | LAMB3, COL1A1, ECOP |
| miR-187 | NS | Down | Down | – |
| miR-138 | Down | Down | Down | RHOC, KRT, ROCK2 |
| miR-422a | Down | NS | Down | – |
| miR-648 | Down | NS | NS | – |
| miR-215 | Down | NS | NS | DHFR, TYMS, DTL, WNK1 |
| miR-663 | Down | NS | NS | – |
| miR-204 | Down | Down | NS | ARPC1B, MMP3, MMP9 |
| miR-135a | Down | Down | NS | APC, FLAP, JAK2 |
Abbreviations: CCPRCC, clear cell papillary renal cell carcinoma; CCRCC, clear cell renal cell carcinoma; PRCC, papillary renal cell carcinoma;
experimentally proven gene targets listed in miRWalk and miRecords; NS, not significantly different compared with matched normal.
Experimentally proven gene targets listed in miRWalk and miRecords.